BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12377320)

  • 1. Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce.
    Das P; Chen MH; Valentine K; Lopes L; Cormack RA; Renshaw AA; Tempany CM; Kumar S; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):698-702. PubMed ID: 12377320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permanent 125I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence.
    Mazeron R; Bajard A; Montbarbon X; Gassa F; Malet C; Rocher F; Clippe S; Bringeon G; Desmettre O; Pommier P
    Radiat Oncol; 2012 Mar; 7():46. PubMed ID: 22449081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSA kinetics and PSA bounce following permanent seed prostate brachytherapy.
    Crook J; Gillan C; Yeung I; Austen L; McLean M; Lockwood G
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):426-33. PubMed ID: 17869662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age.
    Critz FA; Williams WH; Levinson AK; Benton JB; Schnell FJ; Holladay CT; Shrake PD
    J Urol; 2003 Nov; 170(5):1864-7. PubMed ID: 14532794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer.
    Mitchell DM; Swindell R; Elliott T; Wylie JP; Taylor CM; Logue JP
    Radiother Oncol; 2008 Jul; 88(1):102-7. PubMed ID: 18453022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer.
    Critz FA; Williams WH; Benton JB; Levinson AK; Holladay CT; Holladay DA
    J Urol; 2000 Apr; 163(4):1085-9. PubMed ID: 10737471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSA bounce after ¹²⁵I-brachytherapy for prostate cancer as a favorable prognosticator.
    Engeler DS; Schwab C; Thöni AF; Hochreiter W; Prikler L; Suter S; Stucki P; Schiefer J; Plasswilm L; Schmid HP; Putora PM
    Strahlenther Onkol; 2015 Oct; 191(10):787-91. PubMed ID: 26100965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trial.
    Kim DN; Straka C; Cho LC; Lotan Y; Yan J; Kavanagh B; Raben D; Cooley S; Brindle J; Xie XJ; Pistenmaa D; Timmerman R
    Pract Radiat Oncol; 2017; 7(1):e43-e49. PubMed ID: 27637137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis.
    Satoh T; Ishiyama H; Matsumoto K; Tsumura H; Kitano M; Hayakawa K; Ebara S; Nasu Y; Kumon H; Kanazawa S; Miki K; Egawa S; Aoki M; Toya K; Yorozu A; Nagata H; Saito S; Baba S
    BJU Int; 2009 Apr; 103(8):1064-8. PubMed ID: 19040526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Elevation of PSA after prostate radiotherapy: rebound or biochemical recurrence?].
    Toledano A; Chiche R; Lamallem H; Kanoui A; Beley S; Thibault F; Sèbe P
    Prog Urol; 2008 Oct; 18(9):557-61. PubMed ID: 18986625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: a study of 295 patients with a minimum 3-year followup.
    Toledano A; Chauveinc L; Flam T; Thiounn N; Solignac S; Timbert M; Rosenwald JC; Cosset JM
    Brachytherapy; 2006; 5(2):122-6. PubMed ID: 16644467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications.
    Stock RG; Stone NN; Cesaretti JA
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):448-53. PubMed ID: 12738319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between sexual function and prostate-specific antigen bounce after iodine-125 permanent implant brachytherapy for localized prostate cancer.
    Nishihara K; Nakiri M; Chikui K; Suekane S; Matsuoka K; Hattori C; Ogo E; Abe T; Matsumoto Y; Ishitake T
    Int J Urol; 2014 Jul; 21(7):658-63. PubMed ID: 24650159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen bounce after high-dose-rate monotherapy for prostate cancer.
    Mehta NH; Kamrava M; Wang PC; Steinberg M; Demanes J
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):729-33. PubMed ID: 23582852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PSA bounce phenomenon after transperineal interstitial permanent prostate brachytherapy for localized prostate cancer].
    Morita M; Lederer JL; Fukagai T; Shimada M; Yoshida H
    Nihon Hinyokika Gakkai Zasshi; 2004 Mar; 95(3):609-15. PubMed ID: 15103924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen bounce after high-dose-rate prostate brachytherapy and hypofractionated external beam radiotherapy.
    Patel N; Souhami L; Mansure JJ; Duclos M; Aprikian A; Faria S; David M; Cury FL
    Brachytherapy; 2014; 13(5):450-5. PubMed ID: 25023396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term prognostic significance of rising PSA levels following radiotherapy for localized prostate cancer - focus on overall survival.
    Freiberger C; Berneking V; Vögeli TA; Kirschner-Hermanns R; Eble MJ; Pinkawa M
    Radiat Oncol; 2017 Jun; 12(1):98. PubMed ID: 28615058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate specific antigen bounce is related to overall survival in prostate brachytherapy.
    Hinnen KA; Monninkhof EM; Battermann JJ; van Roermund JG; Frank SJ; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):883-8. PubMed ID: 21300477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Good prognosis following a PSA bounce after high dose rate brachytherapy and external radiotherapy in prostate cancer.
    Åström L; Sandin F; Holmberg L
    Radiother Oncol; 2018 Dec; 129(3):561-566. PubMed ID: 30193693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen bounce after curative brachytherapy for early-stage prostate cancer: A study of 274 African-Caribbean patients.
    Leduc N; Atallah V; Creoff M; Rabia N; Taouil T; Escarmant P; Vinh-Hung V
    Brachytherapy; 2015; 14(6):826-33. PubMed ID: 26489920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.